Programmable cellular retention of nanoparticles by replacing the synergistic anion of transferrin

ACS Nano

Volumn 7, Issue 1, 2013, Pages 365-375

  Wu, Li Chen ^a   Chu, Li Wei ^b   Lo, Leu Wei ^b   Liao, Yen Chen ^a   Wang, Yu Chao ^b   Yang, Chung Shi ^a,b  

^a NATIONAL CHI NAN UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

oxalate; programmable particle intracellular retention; synergistic anion . iron release retardation; transferrin

Indexed keywords

ADVERSE EFFECT; CELLULAR RESPONSE; ENDOSOMES; FLUORESCENCE INTENSITIES; IN-VIVO; INTRACELLULAR ACCUMULATION; INTRACELLULAR RETENTION; NANO-DELIVERY SYSTEMS; OXALATE; RETENTION TIME; SYNERGISTIC ANIONS; THERAPEUTIC APPLICATION; TRANSFERRIN;

CELL MEMBRANES; IRON COMPOUNDS; NANOPARTICLES; PARTICLE SIZE;

NEGATIVE IONS;

ANION; NANOPARTICLE; TRANSFERRIN;

ARTICLE; CELL FRACTIONATION; CHEMISTRY; HELA CELL; HUMAN; METABOLISM;

ANIONS; HELA CELLS; HUMANS; NANOPARTICLES; SUBCELLULAR FRACTIONS; TRANSFERRIN;

MLCS; MLOWN;

EID: 84872855137     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn3043397     Document Type: Article

References (37)

1. Byrne, J. D.; Betancourt, T.; Brannon-Peppas, L. Active Targeting Schemes for Nanoparticle Systems in Cancer Therapeutics Adv. Drug Delivery Rev. 2008, 60, 1615-1626
2. Danhier, F.; Feron, O.; Préat, V. To Exploit the Tumor Microenvironment: Passive and Active Tumor Targeting of Nanocarriers for Anti-Cancer Drug Delivery J. Controlled Release 2010, 148, 135-146
3. Bartlett, D. W.; Su, H.; Hildebrandt, I. J.; Weber, W. A.; Davis, M. E. Impact of Tumor-Specific Targeting on the Biodistribution and Efficacy of siRNA Nanoparticles Measured by Multimodality in Vivo Imaging Proc. Natl. Acad. Sci. U. S. A. 2007, 104, 15549-15554
4. Choi, C. H. J.; Alabi, C. A.; Webster, P.; Davis, M. E. Mechanism of Active Targeting in Solid Tumors with Transferrin-Containing Gold Nanoparticles Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 1235-1240
5. Huang, X.; Peng, X.; Wang, Y.; Wang, Y.; Shin, D. M.; El-Sayed, M. A.; Nie, S. A Reexamination of Active and Passive Tumor Targeting by Using Rod-Shaped Gold Nanocrystals and Covalently Conjugated Peptide Ligands ACS Nano 2010, 4, 5887-5896
6. Nam, J.; Won, N.; Jin, H.; Chung, H.; Kim, S. pH-Induced Aggregation of Gold Nanoparticles for Photothermal Cancer Therapy J. Am. Chem. Soc. 2009, 131, 13639-13645
7. Cho, E. C.; Glaus, C.; Chen, J.; Welch, M. J.; Xia, Y. Inorganic Nanoparticle-Based Contrast Agents for Molecular Imaging Trends Mol. Med. 2010, 16, 561-573
8. Gabizon, A.; Horowitz, A. T.; Goren, D.; Tzemach, D.; Shmeeda, H.; Zalipsky, S. In Vivo Fate of Folate-Targeted Polyethylene-Glycol Liposomes in Tumor-Bearing Mice Clin. Cancer Res. 2003, 9, 6551-6559
9. Montet, X.; Funovics, M.; Montet-Abou, K.; Weissleder, R.; Josephson, L. Multivalent Effects of RGD Peptides Obtained by Nanoparticle Display J. Med. Chem. 2006, 49, 6087-6093
10. Phillips, M. A.; Gran, M. L.; Peppas, N. A. Targeted Nanodelivery of Drugs and Diagnostics Nano Today 2010, 5, 143-159
11. Alexis, F.; Pridgen, E.; Molnar, L. K.; Farokhzad, O. C. Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles Mol. Pharmaceutics 2008, 5, 505-515
12. Chithrani, B. D.; Chan, W. C. W. Elucidating the Mechanism of Cellular Uptake and Removal of Protein-Coated Gold Nanoparticles of Different Sizes and Shapes Nano Lett. 2007, 7, 1542-1550
13. Jiang, W.; KimBetty, Y. S.; Rutka, J. T.; ChanWarren, C. W. Nanoparticle-Mediated Cellular Response is Size-Dependent Nat. Nanotechnol. 2008, 3, 145-150
14. Jin, H.; Heller, D. A.; Sharma, R.; Strano, M. S. Size-Dependent Cellular Uptake and Expulsion of Single-Walled Carbon Nanotubes: Single Particle Tracking and a Generic Uptake Model for Nanoparticles ACS Nano 2009, 3, 149-158
15. Perrault, S. D.; Walkey, C.; Jennings, T.; Fischer, H. C.; Chan, W. C. W. Mediating Tumor Targeting Efficiency of Nanoparticles Through Design Nano Lett. 2009, 9, 1909-1915
16. Slowing, I. I.; Vivero-Escoto, J. L.; Zhao, Y.; Kandel, K.; Peeraphatdit, C.; Trewyn, B. G.; Lin, V. S. Y. Exocytosis of Mesoporous Silica Nanoparticles from Mammalian Cells: From Asymmetric Cell-to-Cell Transfer to Protein Harvesting Small 2011, 7, 1526-1532
17. Wang, J.; Tian, S.; Petros, R. A.; Napier, M. E.; DeSimone, J. M. The Complex Role of Multivalency in Nanoparticles Targeting the Transferrin Receptor for Cancer Therapies J. Am. Chem. Soc. 2010, 132, 11306-11313
18. Bellocq, N. C.; Pun, S. H.; Jensen, G. S.; Davis, M. E. Transferrin-Containing, Cyclodextrin Polymer-Based Particles for Tumor-Targeted Gene Delivery Bioconjugate Chem. 2003, 14, 1122-1132
19. Daniels, T. R.; Delgado, T.; Helguera, G.; Penichet, M. L. The Transferrin Receptor Part II: Targeted Delivery of Therapeutic Agents into Cancer Cells Clin. Immunol. 2006, 121, 159-176
20. Davis, M. E.; Zuckerman, J. E.; Choi, C. H. J.; Seligson, D.; Tolcher, A.; Alabi, C. A.; Yen, Y.; Heidel, J. D.; Ribas, A. Evidence of RNAi in Humans from Systemically Administered siRNA via Targeted Nanoparticles Nature 2010, 464, 1067-U140
21. Giannetti, A. M.; Snow, P. M.; Zak, O.; Bjorkman, P. J. Mechanism for Multiple Ligand Recognition by the Human Transferrin Receptor PLoS. Biol. 2003, 1, 341-350
22. Halbrooks, P. J.; Mason, A. B.; Adams, T. E.; Briggs, S. K.; Everse, S. J. The Oxalate Effect on Release of Iron from Human Serum Transferrin Explained J. Mol. Biol. 2004, 339, 217-26
23. Lao, B. J.; Tsai, W.-L. P.; Mashayekhi, F.; Pham, E. A.; Mason, A. B.; Kamei, D. T. Inhibition of Transferrin Iron Release Increases in Vitro Drug Carrier Efficacy J. Controlled Release 2007, 117, 403-412
24. Prabaharan, M.; Grailer, J. J.; Pilla, S.; Steeber, D. A.; Gong, S. Amphiphilic Multi-Arm-Block Copolymer Conjugated with Doxorubicin via pH-Sensitive Hydrazone Bond for Tumor-Targeted Drug Delivery Biomaterials 2009, 30, 5757-5766
25. 3+ to Transferrin in the Absence of Synergistic Anions J. Biol. Chem. 1975, 250, 2177-2181
26. 3+ by Transferrin. Implications for the Interlocking Sites Hypothesis J. Biol. Chem. 1975, 250, 2182-2188
27. Harris, W. R. Thermodynamics of Anion Binding to Human Serum Transferrin Biochemistry 1985, 24, 7412-7418
28. Huang, R. K.; Steinmetz, N. F.; Fu, C. Y.; Manchester, M.; Johnson, J. E. Transferrin-Mediated Targeting of Bacteriophage HK97 Nanoparticles into Tumor Cells Nanomedicine 2011, 6, 55-68
29. Zhang, L. W.; Monteiro-Riviere, N. A. Mechanisms of Quantum Dot Nanoparticle Cellular Uptake Toxicol. Sci. 2009, 110, 138-55
30. Iversen, T. G.; Skotland, T.; Sandvig, K. Endocytosis and Intracellular Transport of Nanoparticles: Present Knowledge and Need for Future Studies Nano Today 2011, 6, 176-185
31. Yang, R. S. H.; Chang, L. W.; Wu, J.-P.; Tsai, M.-H.; Wang, H.-J.; Kuo, Y.-C.; Yeh, T.-K.; Yang, C. S.; Lin, P. Persistent Tissue Kinetics and Redistribution of Nanoparticles, Quantum Dot 705, in Mice: ICP-MS Quantitative Assessment Environ. Health Perspect. 2007, 115
32. Liu, H. Y.; Vu, T. Q. Identification of Quantum Dot Bioconjugates and Cellular Protein Co-localization by Hybrid Gel Blotting Nano Lett. 2007, 7, 1044-1049
33. Edward, J. T. Molecular Volumes and the Stokes-Einstein Equation J. Chem. Educ. 1970, 47, 261
34. Hunter, R. J. Zeta Potential in Colloid Science: Principles and Applications; Academic Press: London, 1981.
35. He, Q. Y.; Mason, A. B.; Woodworth, R. C. Iron Release from Recombinant N-Lobe and Single Point Asp(63) Mutants of Human Transferrin by EDTA Biochem. J. 1997, 328, 439-445
36. Presley, J. F.; Mayor, S.; McGraw, T. E.; Dunn, K. W.; Maxfield, F. R. Bafilomycin A1 Treatment Retards Transferrin Receptor Recycling More than Bulk Membrane Recycling J. Biol. Chem. 1997, 272, 13929-13936
37. Souris, J. S.; Lee, C.-H.; Cheng, S.-H.; Chen, C.-T.; Yang, C.-S.; Ho, J.-a. A.; Mou, C.-Y.; Lo, L.-W. Surface Charge-Mediated Rapid Hepatobiliary Excretion of Mesoporous Silica Nanoparticles Biomaterials 2010, 31, 5564-5574